Junzhe Huang, Changhui Lei, David H Hsi, Minjuan Zheng, Hui Ma, Shengjun Ta, Rui Hu, Chao Han, Wenxia Li, Jing Li, Dong Qu, Fangqi Ruan, Jing Wang, Bo Wang, Xueli Zhao, Jiao Liu, Lina Zhao, Zhe Wang, Jian Yang, Liwen Liu
BACKGROUND: Patients with cardiac tumors may present challenges for surgical resection due to poor clinical condition. Echocardiography-guided transapical radiofrequency ablation for cardiac tumors (TARFACT) potentially offers a less invasive palliative therapy option. OBJECTIVES: This study aimed to evaluate the safety and efficacy of TARFACT. METHODS: Five patients with cardiac tumors (mucinous liposarcoma, myocardial hypertrophy with inflammatory cell infiltration mass, fibrous tissue tumor hyperplasia, myocardial clear cell sarcoma, and cardiac rhabdomyoma) were included...
August 2024: JACC CardioOncology